US Patent Issued to OXFORD UNIVERSITY INNOVATION, Universite Paris-Saclay on Sept. 16 for "Anti-dengue vaccines and antibodies" (British, French Inventors)

ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,836, issued on Sept. 16, was assigned to OXFORD UNIVERSITY INNOVATION Ltd. (Oxford, Great Britain) and Universite Paris-Saclay (Saint Aubin, France).

"Anti-dengue vaccines and antibodies" was invented by Gavin Screaton (London), Juthathip Mongkolsapaya (London), Alexander Rouvinski (Paris), Pablo Guardado-Calvo (Paris), Giovanna Barba-Spaeth (Paris), Stephane Duquerroy (Paris), Marie-Christine Vaney (Paris) and Felix Augusto Rey (Paris).

According to the abstract* released by the U.S. Patent & Trademark Office: "A Dengue virus Envelope Dimer Epitope (EDE) wherein the EDE: c) spans the polypeptides of a Dengue virus Envelope polypeptide dimer; and/or d) is presented on a dimer of...